Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Lorrain Daniel S.
Chief Scientific Officer at Contineum Therapeutics. Filing since 18 Nov 2024.
CIK 0001861550
Company
Date
Role
Action
Shares
Amount
Of holding
CTNM
Contineum Therapeutics, Inc.
9 Jul 2026
Chief Scientific Officer
Sold on a plan
25
$400.00
0.0%
CTNM
Contineum Therapeutics, Inc.
8 Jul 2026
Chief Scientific Officer
Sold on a plan
1,015
$16.24K
0.7%
CTNM
Contineum Therapeutics, Inc.
1 Jul 2026
Chief Scientific Officer
Sold on a plan
8,353
$132.29K
5.8%
CTNM
Contineum Therapeutics, Inc.
30 Jun 2026
Chief Scientific Officer
Sold on a plan
28,826
$462.29K
17.1%
CTNM
Contineum Therapeutics, Inc.
1 Jun 2026
Chief Scientific Officer
Sold on a plan
4,170
$54.86K
2.9%
CTNM
Contineum Therapeutics, Inc.
1 May 2026
Chief Scientific Officer
Sold on a plan
4,170
$54.69K
2.8%
CTNM
Contineum Therapeutics, Inc.
6 Apr 2026
Chief Scientific Officer
Sold on a plan
4,170
$56.01K
2.7%
CTNM
Contineum Therapeutics, Inc.
2 Mar 2026
Chief Scientific Officer
Sold on a plan
4,170
$62.59K
2.7%
CTNM
Contineum Therapeutics, Inc.
25 Feb 2026
Chief Scientific Officer
Sold on a plan
3,824
$61.23K
2.4%
CTNM
Contineum Therapeutics, Inc.
24 Feb 2026
Chief Scientific Officer
Sold on a plan
4,300
$68.94K
2.7%
CTNM
Contineum Therapeutics, Inc.
19 Feb 2026
Chief Scientific Officer
Sold on a plan
100
$1.60K
0.1%
CTNM
Contineum Therapeutics, Inc.
11 Feb 2026
Chief Scientific Officer
Sold on a plan
400
$6.40K
0.3%
CTNM
Contineum Therapeutics, Inc.
3 Feb 2026
Chief Scientific Officer
Sold on a plan
4,170
$62.31K
2.6%
CTNM
Contineum Therapeutics, Inc.
5 Jan 2026
Chief Scientific Officer
Sold on a plan
4,170
$43.54K
2.5%
CTNM
Contineum Therapeutics, Inc.
23 Dec 2025
Chief Scientific Officer
Sold on a plan
4,170
$51.01K
2.5%
CTNM
Contineum Therapeutics, Inc.
25 Nov 2024
Chief Scientific Officer
Sold on a plan
1,010
$16.18K
0.6%
CTNM
Contineum Therapeutics, Inc.
18 Nov 2024
Chief Scientific Officer
Sold on a plan
6,190
$101.42K
3.5%
17 decisions on file.
